Pharmakokinetics of Mistletoe Lectins after Intravenous Application of a Mistletoe Product in Healthy Subjects

Mistletoe lectins (ML) have cytotoxic and immunomodulating properties, and subcutaneously applied mistletoe products (MP) containing ML have approval for supportive cancer treatment. MP are also given off-label intravenously, but data about pharmacokinetics are widely lacking. Therefore, the aim of...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Ann-Kathrin Lederer, Sabine Rieger, Michael Schink, Roman Huber
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2024-02-01
سلاسل:	Pharmaceuticals
الموضوعات:	mistletoe lectins phase I clinical trial viscum album pharmacokinetics reversible liver injury
الوصول للمادة أونلاين:	https://www.mdpi.com/1424-8247/17/3/278
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!